[HTML][HTML] Erlotinib in wild type epidermal growth factor receptor non-small cell lung cancer: A systematic review
AR Jazieh, R Al Sudairy, N Abu-Shraie… - Annals of thoracic …, 2013 - journals.lww.com
BACKGROUND: Targeting epidermal growth factor receptors (EGFR) is an innovative
approach to managing non-small cell lung cancer (NSCLC) which harbors EGFR mutation …
approach to managing non-small cell lung cancer (NSCLC) which harbors EGFR mutation …
Erlotinib in wild type epidermal growth factor receptor non-small cell lung cancer: A systematic review.
AR Jazieh, R Al Sudairy, N Abu-Shraie… - Annals of Thoracic …, 2013 - europepmc.org
Background Targeting epidermal growth factor receptors (EGFR) is an innovative approach
to managing non-small cell lung cancer (NSCLC) which harbors EGFR mutation. However …
to managing non-small cell lung cancer (NSCLC) which harbors EGFR mutation. However …
Erlotinib in wild type epidermal growth factor receptor non-small cell lung cancer: A systematic review
AR Jazieh, R Al Sudairy… - Annals of thoracic …, 2013 - pubmed.ncbi.nlm.nih.gov
Background Targeting epidermal growth factor receptors (EGFR) is an innovative approach
to managing non-small cell lung cancer (NSCLC) which harbors EGFR mutation. However …
to managing non-small cell lung cancer (NSCLC) which harbors EGFR mutation. However …
Erlotinib in wild type epidermal growth factor receptor non-small cell lung cancer: A systematic review
AR Jazieh, R Al Sudairy… - Annals of …, 2013 - mayoclinic.elsevierpure.com
Background: Targeting epidermal growth factor receptors (EGFR) is an innovative approach
to managing non-small cell lung cancer (NSCLC) which harbors EGFR mutation. However …
to managing non-small cell lung cancer (NSCLC) which harbors EGFR mutation. However …
Erlotinib in wild type epidermal growth factor receptor non-small cell lung cancer: A systematic review
AR Jazieh, R Al Sudairy, N Abu-Shraie… - Annals of Thoracic …, 2013 - search.proquest.com
Background: Targeting epidermal growth factor receptors (EGFR) is an innovative approach
to managing non-small cell lung cancer (NSCLC) which harbors EGFR mutation. However …
to managing non-small cell lung cancer (NSCLC) which harbors EGFR mutation. However …
Erlotinib in wild type epidermal growth factor receptor non-small cell lung cancer: A systematic review.
A Rahman Jazieh, R Al Sudairy… - Annals of Thoracic …, 2013 - search.ebscohost.com
BACKGROUND: Targeting epidermal growth factor receptors (EGFR) is an innovative
approach to managing non-small cell lung cancer (NSCLC) which harbors EGFR mutation …
approach to managing non-small cell lung cancer (NSCLC) which harbors EGFR mutation …
[PDF][PDF] Erlotinib in wild type epidermal growth factor receptor non‑small cell lung cancer: A systematic review
AR Jazieh, R Al Sudairy, N Abu‑Shraie… - Annals of Thoracic …, 2013 - cyberleninka.org
BACKGROUND: Targeting epidermal growth factor receptors (EGFR) is an innovative
approach to managing non‑small cell lung cancer (NSCLC) which harbors EGFR mutation …
approach to managing non‑small cell lung cancer (NSCLC) which harbors EGFR mutation …
Erlotinib in wild type epidermal growth factor receptor non-small cell lung cancer: A systematic review
AR Jazieh, R Al Sudairy, N Abu-Shraie… - Annals of Thoracic …, 2013 - go.gale.com
Background: Targeting epidermal growth factor receptors (EGFR) is an innovative approach
to managing non-small cell lung cancer (NSCLC) which harbors EGFR mutation. However …
to managing non-small cell lung cancer (NSCLC) which harbors EGFR mutation. However …
[PDF][PDF] Erlotinib in wild type epidermal growth factor receptor non‑small cell lung cancer: A systematic review
AR Jazieh, R Al Sudairy, N Abu‑Shraie… - Annals of Thoracic …, 2013 - academia.edu
BACKGROUND: Targeting epidermal growth factor receptors (EGFR) is an innovative
approach to managing non‑small cell lung cancer (NSCLC) which harbors EGFR mutation …
approach to managing non‑small cell lung cancer (NSCLC) which harbors EGFR mutation …
[HTML][HTML] Erlotinib in wild type epidermal growth factor receptor non-small cell lung cancer: A systematic review
AR Jazieh, R Al Sudairy, N Abu-Shraie… - Annals of Thoracic …, 2013 - ncbi.nlm.nih.gov
BACKGROUND: Targeting epidermal growth factor receptors (EGFR) is an innovative
approach to managing non-small cell lung cancer (NSCLC) which harbors EGFR mutation …
approach to managing non-small cell lung cancer (NSCLC) which harbors EGFR mutation …